In India, the CDSCO framework under the Drugs and Cosmetics Act covers Schedule H and H1 categories for prescription medicines, but most grey-market peptides are not classified under any schedule at all, creating an effective regulatory absence
10.1053/j.gastro.2021.04.020 39
There is also a regulatory and safety dimension that KLOW marketing tends to omit
Improved Tissue Elasticity and Resilience: Early findings show improved flexibility and reduced scar formation in soft tissues
Truth: While weight loss is a common benefit, GLP-1 medications are primarily designed to regulate blood sugar and improve metabolic health
The injected solution, containing Riboflavin (vitamin B2) and other premium ingredients, is thought to disrupt the integrity of fat cell membranes, causing them to break down